| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |